Farther Finance Advisors’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.51K Buy
1,295
+1,100
+564% +$6.64K ﹤0.01% 4651
2026
Q1
$1.24K Sell
195
-588
-75% -$4.88K ﹤0.01% 5043
2025
Q4
$8.16K Buy
783
+677
+639% +$6.79K ﹤0.01% 4044
2025
Q3
$953 Buy
+106
New +$930 ﹤0.01% 4383
2025
Q2
Sell
-4
Closed -$101 4637
2025
Q1
$101 Sell
4
-4
-50% -$119 ﹤0.01% 4060
2024
Q4
$275 Hold
8
﹤0.01% 3579
2024
Q3
$395 Buy
8
+4
+100% +$205 ﹤0.01% 3475
2024
Q2
$227 Hold
4
﹤0.01% 3471
2024
Q1
$202 Hold
4
﹤0.01% 3271
2023
Q4
$161 Sell
4
-36
-90% -$1.06K ﹤0.01% 3253
2023
Q3
$1.12K Buy
+40
New +$1.19K ﹤0.01% 2055

Other funds holding RXST

Farther Finance Advisors's RXST Position: Q2 2026 in Review

Farther Finance Advisors increased its RxSight (RXST) stake by 564% in Q2 2026, buying an estimated $6.64K and bringing the position to 1,295 shares worth $6.51K. The position accounts for ﹤0.01% of the portfolio, ranked #4651.

Farther Finance Advisors first reported a position in RXST in Q3 2023 and has held it in 11 quarters since. The position peaked at $8.16K in Q4 2025. 7 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Farther Finance Advisors held 1,295 shares of RxSight worth $6.51K as of Q2 2026.
  • Farther Finance Advisors bought 1,100 RxSight shares in Q2 2026, an estimated $6.64K.
  • RxSight made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4651 holding.
  • Farther Finance Advisors first reported a position in RxSight in Q3 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's RxSight position peaked at $8.16K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.